March 19, 2009 | Bangalore, India and Palo Alto, California: MetricStream Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, today announced Fresenius Kabi Oncology as a new customer for its quality and compliance management solutions.

Dabur Pharma, a leading company for cancer research and oncology drugs, was renamed  Fresenius Kabi Oncology after its acquisition by Fresenius Kabi, the leader in infusion therapy and clinical nutrition in Europe, Latin America, Asia Pacific as well as in the US, where it is a leading supplier of IV generic drugs. Fresenius Kabi has more than 20,000 employees worldwide achieved sales of € 2,030 million in 2007.

“We are pleased to have Fresenius Kabi Oncology as a customer,” said Shankar Bhaskaran, Senior Director and Head of International at MetricStream. “We look forward to working with Fresenius Kabi Oncology to make this initiative a success.”

Deployed at major life science companies across the globe, MetricStream provides an industry leading platform to drive regulatory compliance and quality management programs through configurable workflows, real-time reporting and embedded best practices.

About MetricStream

MetricStream is the independent market leader in enterprise cloud applications for governance, risk, compliance (GRC), and quality management. MetricStream apps and software solutions improve business performance by strengthening risk management, corporate governance, regulatory compliance, audit management, vendor governance, and quality management for organizations across industries, including banking and financial services, health care, life sciences, energy and utilities, consumer brands, government, technology, and manufacturing. MetricStream is headquartered in Palo Alto, California, with an operations and GRC innovation center in Bengaluru, India, and sales and operations support in 12 other cities globally.(

Press contact

[email protected]

Get a demo Download RFP Template Pricing Contact